Patents by Inventor Dina UZRI

Dina UZRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230417761
    Abstract: Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
    Type: Application
    Filed: May 5, 2023
    Publication date: December 28, 2023
    Inventors: Bradley T. MESSMER, Dina UZRI, Jessie-Farah FECTEAU
  • Patent number: 11680948
    Abstract: Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: June 20, 2023
    Assignee: ABREOS BIOSCIENCES, INC.
    Inventors: Bradley T. Messmer, Dina Uzri, Jessie-Farah Fecteau
  • Publication number: 20210318298
    Abstract: Disclosed is a covalently-linked multilayered three-dimensional matrix comprising capture molecules, linkers and spacers (referred to as a Molecular Net) for specific and sensitive analyte capture from a sample. Also disclosed herein is a Molecular Net comprising covalently-linked multilayered three-dimensional matrix comprising more than one type of capture molecule and more than one type of linker and may comprise one or more spacer for specific and sensitive capture of more than one type of analyte from a sample. A Molecular Net may comprise a pseudorandom nature. Use of various capture molecules, linkers and spacers in a Molecular Net may confer unique binding properties to a Molecular Net. Porosity, binding affinity, size exclusion abilities, filtration abilities, concentration abilities and signal amplification abilities of a Molecular Net may be varied and depend on the nature of components used in its fabrication.
    Type: Application
    Filed: December 21, 2020
    Publication date: October 14, 2021
    Applicant: Sienna Cancer Diagnostics Inc.
    Inventors: Emily A. STEIN, Bruce PHELPS, Robert PLACE, Dina UZRI
  • Publication number: 20210285959
    Abstract: Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
    Type: Application
    Filed: August 11, 2017
    Publication date: September 16, 2021
    Inventors: Bradley T. MESSMER, Dina UZRI, Jessie-Farah FECTEAU
  • Patent number: 10900962
    Abstract: Disclosed is a covalently-linked multilayered three-dimensional matrix comprising capture molecules, linkers and spacers (referred to as a Molecular Net) for specific and sensitive analyte capture from a sample. Also disclosed herein is a Molecular Net comprising covalently-linked multilayered three-dimensional matrix comprising more than one type of capture molecule and more than one type of linker and may comprise one or more spacer for specific and sensitive capture of more than one type of analyte from a sample. A Molecular Net may comprise a pseudorandom nature. Use of various capture molecules, linkers and spacers in a Molecular Net may confer unique binding properties to a Molecular Net. Porosity, binding affinity, size exclusion abilities, filtration abilities, concentration abilities and signal amplification abilities of a Molecular Net may be varied and depend on the nature of components used in its fabrication.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: January 26, 2021
    Assignee: Sienna Cancer Diagnostics Inc.
    Inventors: Emily A. Stein, Bruce Phelps, Robert Place, Dina Uzri
  • Publication number: 20180143188
    Abstract: Disclosed is a covalently-linked multilayered three-dimensional matrix comprising capture molecules, linkers and spacers (referred to as a Molecular Net) for specific and sensitive analyte capture from a sample. Also disclosed herein is a Molecular Net comprising covalently-linked multilayered three-dimensional matrix comprising more than one type of capture molecule and more than one type of linker and may comprise one or more spacer for specific and sensitive capture of more than one type of analyte from a sample. A Molecular Net may comprise a pseudorandom nature. Use of various capture molecules, linkers and spacers in a Molecular Net may confer unique binding properties to a Molecular Net. Porosity, binding affinity, size exclusion abilities, filtration abilities, concentration abilities and signal amplification abilities of a Molecular Net may be varied and depend on the nature of components used in its fabrication.
    Type: Application
    Filed: July 6, 2017
    Publication date: May 24, 2018
    Applicant: Sevident, Inc.
    Inventors: Emily A. STEIN, Bruce PHELPS, Robert PLACE, Dina UZRI
  • Patent number: 9733242
    Abstract: Disclosed is a covalently-linked multilayered three-dimensional matrix comprising capture molecules, linkers and spacers (referred to as a Molecular Net) for specific and sensitive analyte capture from a sample. Also disclosed herein is a Molecular Net comprising covalently-linked multilayered three-dimensional matrix comprising more than one type of capture molecule and more than one type of linker and may comprise one or more spacer for specific and sensitive capture of more than one type of analyte from a sample. A Molecular Net may comprise a pseudorandom nature. Use of various capture molecules, linkers and spacers in a Molecular Net may confer unique binding properties to a Molecular Net. Porosity, binding affinity, size exclusion abilities, filtration abilities, concentration abilities and signal amplification abilities of a Molecular Net may be varied and depend on the nature of components used in its fabrication.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 15, 2017
    Assignee: Sevident, Inc.
    Inventors: Emily Stein, Bruce Phelps, Robert Place, Dina Uzri
  • Publication number: 20140315759
    Abstract: Disclosed is a covalently-linked multilayered three-dimensional matrix comprising capture molecules, linkers and spacers (referred to as a Molecular Net) for specific and sensitive analyte capture from a sample. Also disclosed herein is a Molecular Net comprising covalently-linked multilayered three-dimensional matrix comprising more than one type of capture molecule and more than one type of linker and may comprise one or more spacer for specific and sensitive capture of more than one type of analyte from a sample. A Molecular Net may comprise a pseudorandom nature. Use of various capture molecules, linkers and spacers in a Molecular Net may confer unique binding properties to a Molecular Net. Porosity, binding affinity, size exclusion abilities, filtration abilities, concentration abilities and signal amplification abilities of a Molecular Net may be varied and depend on the nature of components used in its fabrication.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 23, 2014
    Applicant: Sevident, Inc.
    Inventors: Emily STEIN, Bruce PHELPS, Robert PLACE, Dina UZRI
  • Patent number: D800912
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: October 24, 2017
    Assignee: ABREOS BIOSCIENCES, INC.
    Inventors: Dina Uzri, Benedict L. Zin, Bradley Todd Messmer, Inhoe Kim, Gad Shaanan, Jessie-Farah Fecteau